AI and biotech continue to converge and companies cracking the new paradigm of AI-fueled discovery and development, like Peptilogics who just announced a $78M Series B+ raise, are surging ahead. On the data driven-healthcare side, AI software and agents continue to haul in big investments, but the winners are grounded in core system problems and deep healthcare expertise as we showed at HLTH 2025. These trends are adding wind to the sails of the surging Pittsburgh ecosystem.
Get insights delivered to your inbox.
Enter your email to get access to the resource
Access directly from its original publisher.
